GR3015924T3 - Catabolic enzymes for the induction of the tumour necrosis factor (TNF). - Google Patents

Catabolic enzymes for the induction of the tumour necrosis factor (TNF).

Info

Publication number
GR3015924T3
GR3015924T3 GR950401045T GR950401045T GR3015924T3 GR 3015924 T3 GR3015924 T3 GR 3015924T3 GR 950401045 T GR950401045 T GR 950401045T GR 950401045 T GR950401045 T GR 950401045T GR 3015924 T3 GR3015924 T3 GR 3015924T3
Authority
GR
Greece
Prior art keywords
tnf
induction
necrosis factor
tumour necrosis
catabolic enzymes
Prior art date
Application number
GR950401045T
Other languages
English (en)
Inventor
Karl Ransberger
Gerhard Dr Stauder
Original Assignee
Mucos Emulsions Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucos Emulsions Gmbh filed Critical Mucos Emulsions Gmbh
Publication of GR3015924T3 publication Critical patent/GR3015924T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR950401045T 1989-10-06 1995-04-25 Catabolic enzymes for the induction of the tumour necrosis factor (TNF). GR3015924T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89118628A EP0421023B1 (de) 1989-10-06 1989-10-06 Katabolische Enzyme zur Induktion des Tumornekrose-Faktors (TNF)

Publications (1)

Publication Number Publication Date
GR3015924T3 true GR3015924T3 (en) 1995-07-31

Family

ID=8201995

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950401045T GR3015924T3 (en) 1989-10-06 1995-04-25 Catabolic enzymes for the induction of the tumour necrosis factor (TNF).

Country Status (6)

Country Link
US (1) US5223406A (el)
EP (1) EP0421023B1 (el)
AT (1) ATE119780T1 (el)
DE (1) DE58909121D1 (el)
ES (1) ES2072280T3 (el)
GR (1) GR3015924T3 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038546B1 (es) * 1991-11-08 1994-02-16 Andromaco Lab Procedimiento de obtencion de un producto de naturaleza polipeptidica con actividad inhibidora de la hiperproduccion del factor de necrosis tumoral.
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain
CZ283972B6 (cs) * 1995-05-17 1998-07-15 František Mudr. Trnka Farmaceutický prostředek s modulačním účinkem na zhoubné nádory a jeho použití
JP2001513636A (ja) 1997-02-25 2001-09-04 コルテクス（ユーケイ）リミティッド ブロメラインの成分
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
DE19726255C2 (de) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Beeinflussung von Cytokinen durch proteolytische Enzyme und Rutosid
DE19726248C2 (de) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Verwendung proteolytischer Enzyme und Rutosid zur Behandlung von septischem Schock
DE19726253C2 (de) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Verwendung von mindestens einem proteolytischen Enzym und Rutosid zur Behandlung von Glomerulonephritis
US6413512B1 (en) * 1998-02-13 2002-07-02 National Enzyme Company Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
US7112438B2 (en) 1999-01-04 2006-09-26 Dyax Corp. Binding molecules for human factor VIII and factor VIII-like proteins
US20080139790A1 (en) * 2006-12-08 2008-06-12 Jennings Philip A Chimeric antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219027A (en) * 1986-01-24 1989-09-27 Genentech Inc Antiviral composition containing interferon tumour necrosis factor and/or lymphotoxin
ATE87214T1 (de) * 1987-09-30 1993-04-15 Mucos Emulsions Gmbh Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).

Also Published As

Publication number Publication date
DE58909121D1 (de) 1995-04-20
ATE119780T1 (de) 1995-04-15
EP0421023B1 (de) 1995-03-15
EP0421023A1 (de) 1991-04-10
ES2072280T3 (es) 1995-07-16
US5223406A (en) 1993-06-29

Similar Documents

Publication Publication Date Title
MY120693A (en) Human bikunin
AU558711B2 (en) Enzyme preparation for treatment of liver and kidney disease
MX9804262A (es) Inhibidores derivados de d-aminoacidos de proteasas de cisteina y serina.
NZ506783A (en) Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
DE3785036D1 (de) Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
GR3015924T3 (en) Catabolic enzymes for the induction of the tumour necrosis factor (TNF).
AU553654B2 (en) Combination of fungal protease and pancreatin to enzymatically hydrolyse protein
AU6458396A (en) Phosphorous-containing cysteine and serine protease inhibitors
HU9602886D0 (en) Methods of prouducing effective recombinant serine protease inhibitors and uses of these inhibitors
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
UA66793C2 (uk) Лептин як стримувач швидкого збільшення пухлини клітини
ZA986673B (en) Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders
DE69333639D1 (en) Trypsininhibitoren
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
NO955258L (no) Medisinsk anvendelse av enzymer
CA2176771A1 (en) Pharmaceutical preparation with modulatory effect on malign tumours and its usage
EP0960117A4 (en) ON FIBROBLASTS GROWTH FACTOR HOMOLOGICAL FACTORS (FHFs) AND METHOD OF APPLICATION
AU2676801A (en) Xylosyltransferase and isoforms thereof
CA2293808A1 (en) Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
ES2059666T3 (es) Utilizacion de enzimas catabolicas para el tratamiento de una infeccion vih.
AU2821000A (en) Matrix protein compositions for induction of apoptosis
GB9626472D0 (en) New use of comt inhibitors
AP2003002901A0 (en) Use of HIV-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
CO4920227A1 (es) Histidina-n-bencil glicinamida sustituida con cicloalquilos .
AU551478B2 (en) Detection of esterolytic and/or proteolytic enzymes